James R Rigas Selected Research

James R Rigas Research Topics

Disease

24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 02/2001
15	Neoplasms (Cancer) 12/2013 - 11/2004
12	Lung Neoplasms (Lung Cancer) 12/2013 - 01/2004
4	Carcinogenesis 12/2013 - 01/2005
3	Disease Progression 07/2016 - 06/2007
3	Fatigue 01/2012 - 01/2010
2	Brain Neoplasms (Brain Tumor) 07/2016 - 12/2015
2	Febrile Neutropenia 10/2013 - 01/2004
2	Carcinoma (Carcinomatosis) 04/2013 - 06/2007
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2013 - 03/2010
2	Necrosis 01/2013 - 06/2011
2	Neutropenia 01/2012 - 01/2004
1	Hypertriglyceridemia 09/2018
1	Melanoma (Melanoma, Malignant) 07/2016
1	Lymphoma (Lymphomas) 10/2013
1	Adenocarcinoma 06/2013
1	Pneumonia (Pneumonitis) 01/2012
1	Ileus 01/2012
1	Inflammation (Inflammations) 12/2011
1	Cachexia 12/2011
1	Anemia 12/2011
1	Thromboembolism 12/2011
1	Thrombophilia 12/2011
1	Sepsis (Septicemia) 01/2010
1	Dyspnea (Shortness of Breath) 01/2010
1	Diarrhea 01/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2009
1	Lung Diseases (Lung Disease) 11/2009
1	Neoplasm Micrometastasis 06/2007
1	Mediastinal Diseases 06/2007
1	Pain (Aches) 12/2005
1	Esophageal Neoplasms (Esophageal Cancer) 04/2005
1	Stomach Neoplasms (Stomach Cancer) 04/2005
1	Astrocytoma (Pilocytic Astrocytoma) 02/2005
1	Leukopenia 02/2005
1	Glioma (Gliomas) 02/2005
1	Glioblastoma (Glioblastoma Multiforme) 02/2005

Drug/Important Bio-Agent (IBA)

8	Docetaxel (Taxotere)FDA Link 10/2013 - 02/2001
7	ErbB Receptors (EGF Receptor)IBA 12/2013 - 11/2004
5	Bexarotene (LGD1069)FDA Link 09/2018 - 01/2005
4	Tyrosine Kinase InhibitorsIBA 09/2019 - 11/2004
4	Carboplatin (JM8)FDA LinkGeneric 09/2018 - 01/2004
4	Cyclin D1IBA 06/2011 - 11/2004
4	Vinorelbine (Navelbine)FDA LinkGeneric 01/2011 - 05/2002
4	RetinoidsIBA 03/2007 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 01/2004
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2011 - 11/2004
3	Gemcitabine FDA Link 01/2010 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2016 - 10/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2011 - 02/2001
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2011 - 11/2004
2	Filgrastim (Neupogen)FDA Link 01/2010 - 02/2005
2	CyclinsIBA 01/2007 - 11/2004
2	taxaneIBA 04/2005 - 01/2004
1	osimertinibIBA 09/2019
1	dabrafenibIBA 07/2016
1	trametinibIBA 07/2016
1	Mitogen-Activated Protein KinasesIBA 07/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	epothilone B (EPO906)IBA 12/2015
1	Lysine (L-Lysine)FDA Link 10/2013
1	Arginine (L-Arginine)FDA Link 10/2013
1	Phosphotransferases (Kinase)IBA 10/2013
1	PhosphopeptidesIBA 10/2013
1	Capecitabine (Xeloda)FDA Link 04/2013
1	MucinsIBA 01/2013
1	ABT751IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2011
1	Epidermal Growth Factor (EGF)IBA 12/2011
1	clazakizumabIBA 12/2011
1	Cyclin EIBA 06/2011
1	Pemetrexed (MTA)FDA Link 06/2010
1	Proteasome InhibitorsIBA 04/2010
1	Bortezomib (Velcade)FDA Link 04/2010
1	Lapatinib (GW572016)FDA Link 03/2010
1	pegfilgrastim (Neulasta)FDA Link 01/2010
1	ORALIT (ORS)IBA 11/2009
1	SeleniumIBA 11/2009
1	ArsenicIBA 11/2009
1	Cyclin D3IBA 03/2007
1	CarcinogensIBA 01/2007
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2006
1	Warfarin (Coumadin)FDA LinkGeneric 10/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2005
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2005
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2005
1	Antineoplastic Agents (Antineoplastics)IBA 01/2005

Therapy/Procedure

14	Therapeutics 01/2019 - 11/2004
10	Drug Therapy (Chemotherapy) 12/2015 - 02/2001
3	Chemoprevention 01/2007 - 11/2004
2	Adjuvant Chemotherapy 01/2011 - 04/2007
2	Combination Drug Therapy (Combination Chemotherapy) 01/2005 - 05/2002
1	Thoracotomy 10/2013
1	Radiotherapy 04/2013
1	Intravenous Administration 06/2007
1	Chemoradiotherapy 06/2007
1	Secondary Prevention 10/2006